G01N 33/5762
Hepatitis b core antigen
Official title: {Hepatitis B core antigen}
G01N33/5762 (Hepatitis b core antigen) appears on 23 US grants and 16 published applications in this corpus.
Search patents in G01N- Granted patents
- 23
- Published applications
- 16
- Assignees
- 25
- Inventors
- 83
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 3 |
| 2024 | 0 | 1 |
| 2025 | 2 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method and antibody for detection of HBcAg12 May 2026US 12,624,090 B2Xiamen Innodx Biotech Co., Ltd
- Use of HLA-A*11:01-restricted hepatitis B virus (HBV) peptides for identifying HBV-specific CD8+ T cells16 Sep 2025US 12,414,990 B2Agency for Science, Technology and Research
- HBV diagnostic, prognostic, and therapeutic methods and products25 Feb 2025US 12,235,273 B2Abbott Laboratories
- Hepatitis B virus capsid assembly5 Feb 2019US 10,196,701 B2The Penn State Research Foundation
- Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect24 Apr 2018US 9,952,217 B2Xiamen Innovax Biotech Co., Ltd.
- Affinity particle, test reagent, and detection method for detecting target immunoglobulin g in human specimen21 Aug 2025US 2025/0264472 A1Canon Kabushiki Kaisha
- Hbv diagnostic, prognostic, and therapeutic methods and products26 Jun 2025US 2025/0208140 A1Abbott Laboratories
- Hbv diagnostic, prognostic, and therapeutic methods and products11 Apr 2024US 2024/0118278 A1Abbott Laboratories
- In vitro hbv core protein assay20 Jul 2023US 2023/0228736 A1
- Use of hla-a*11:01-restricted hepatitis b virus (hbv) peptides for identifying hbv-specific cd8+ t cells23 Mar 2023US 2023/0087348 A1Agency for Science, Technology and Research
Most cited
By later US patents
- Method and composition for the simultaneous and discrete analysis of multiple analytes112US 5,567,627 ATrans-Med Biotech, Incorporated · 1996
- Device for performing solid-phase diagnostic assay74US 5,244,630 AAbbott Laboratories · 1993
- Use of a mixture of conjugated and unconjugated solid phase binding reagent to enhance the performance of assays54US 5,164,299 AE. I. Du Pont de Nemours and Company · 1992
- Confirmatory immunoassay using microparticle separation34US 5,141,848 AAbbott Laboratories · 1992
- Method of preparing hepatitis B core antigen15US 4,102,996 AMerck & Co., Inc. · 1978